ORIENS above the noise

Home
Archive
About
Oriens #200
Noise On the virus et al.: Chinese vaccine makers Sinopharm and CanSino claim their vaccines have an efficacy of 72.5% and 65%, respectively. Moderna…
 • 
Editor
Oriens #199
Noise Markets are mixed. Japan’s Topix 500 dropped 1.98% while the S&P Asia 50 climbed 0.08%, respectively. Europe’s Stoxx 50 climbed 0.59% at 7:51 a.m…
 • 
Editor
Oriens #198
Alex Schober from FrontierView contributed to our report today. Alex covers the Southern Cone. Reach out to him for anything related to Latin America or…
 • 
Editor
Oriens #197
Noise On the virus et al., we have optimistic news for once. And we’re glad that the prospects of going back to 2019 are brighter than ever: The…
 • 
Editor
Oriens #196
Noise On the virus et al.: Bloomberg expects a “vaccine surprise” for the U.S. in spring, with doses doubling over the next couple of weeks. Fingers…
 • 
Editor
Oriens #195
Noise On the virus et al: Britain to start “human challenge” trials; i.e., paying young, healthy people to get deliberately infected to test vaccines…
 • 
Editor
Oriens #194
Noise Markets are mixed. Japan’s Topix 500 dropped 0.22% while the and the S&P Asia 50 climbed 0.35%. Europe’s Stoxx 50 dropped 0.21% at 7:48 a.m. EST…
 • 
Editor
ORIENS above the noise
ORIENS above the noise
ORIENS aims at providing members of the financial community with the most relevant information in a timely manner. 

ORIENS above the noise

AboutArchiveSitemap
© 2024 Editor
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great culture